Eric Aguiar, M.D.

Board Chairperson
Partner, Aisling Capital

Avanish Vellanki, M.B.A.

Chief Executive Officer
Garuda Therapeutics, Inc.

Adam R. Craig, M.D., Ph.D., M.B.A.

Former CEO
CTI BioPharma

Carl Gordon, Ph.D., CFA

Managing Partner
OrbiMed

Steve Liapis, Ph.D.

Managing Director
Northpond Ventures

Rahul Singhvi, Sc.D.

Co-Founder and CEO
National Resilience, Inc.

Laurence Reid, Ph.D.

Former CEO
Decibel Therapeutics

Raymond J. Kelleher, M.D., Ph.D.

Managing Director at Cormorant Asset Management

David Scadden, M.D.

Co-Director, Harvard Stem Cell Institute

Gerald and Darlene Jordan Professor of Medicine, Harvard University

Sean Morrison, Ph.D.

Investigator, Howard Hughes Medical Institute

Founder & Director, Children’s Research Institute at UT Southwestern Medical Center

Robert Negrin, M.D.

Professor of Medicine, Stanford University

Former Chief of the Division of Blood and Marrow Transplantation, Stanford University

Jerome Ritz, M.D.

Executive Director, Connell and O’Reilly Families Cell Manipulation Core Facility, Dana-Farber Cancer Institute

Professor of Medicine, Harvard Medical School

Marcel van den Brink, M.D., Ph.D.

Head, Division of Hematologic Malignancies &
Alan N. Houghton Chair, Memorial Sloan Kettering Cancer Center

Ivan Maillard, M.D., Ph.D.

Professor of Hematology-Oncology, University of Pennsylvania School of Medicine

Katja G. Weinacht, M.D., Ph.D.

Assistant Professor of Pediatrics, Stanford University School of Medicine

John E. Wagner, M.D.

Distinguished McKnight Professor of Pediatrics, University of Minnesota